[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fPceBnQXtJZ0pMGAh1CVqrfeAwjUmPIH6eHbGcsPLjPQ":8,"$fQWCZB2kpXb3On7Qjds8Ry2LRgKEC4cQIpil1ba6ufuM":55,"$fRv1E0ZQyrvjjofDxC9hDD7CPQgnsYEQJBJz-e9JH5c0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},74980,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"奥沙利铂、卡培他滨等化疗药与辅助药‍全攻略","","https://ystcdn.venuertc.com/venue/AI/1caa3090-7f0a-46be-91be-566f9dbb9cfe.jpg","\u003C!-- 药品安全用药知识页 | 直肠癌T4N1M0围手术期典用药讲解 -->\n\u003Cdiv class=\"safe-drug-guide-root\">\n  \u003Ch1 id=\"material_title\" class=\"sdg-title\">奥沙利铂、卡培他滨等化疗药与辅助药‍全攻略\u003C/h1>\n  \u003Cdiv class=\"sdg-divider\">\u003C/div>\n  \u003Csection class=\"sdg-section sdg-intro\">\n    \u003Cp class=\"sdg-intro-text\">\n      说起来，癌症围手术期用药涉及的药品特别多，奥沙利铂、卡培他滨、托烷司琼、利可君、胸腺法新等经常被提及。每种药都有独特的作用机理或辅助价值，但安全高效地应用才是关键。本文将一口气梳理7大核心用药细节，涉及给药方法、相互作用、不良反应、特殊人群用法、储存及用药补救等安全要点，请务必看完，避免临床常见药物风险。\n    \u003C/p>\n  \u003C/section>\n  \u003C!-- 用药要点  -->\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#f7fafc 60%,#e6ecfa 100%)\">1️⃣ 服用时间与给药方法\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Ch3 class=\"sdg-h3\">奥沙利铂（Oxaliplatin）\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          静脉输注为主，注射时间通常2小时或更长。正确做法：全程静滴，不可推注或肌注。\u003Cbr>\n          建议在门诊或医院专人监护下使用，避免自行操作。\n        \u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">卡培他滨（Capecitabine）\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>为口服片剂。正确做法：\u003Cb>餐后30分钟内\u003C/b>以整片吞服，勿嚼碎或掰开。\u003C/li>\n        \u003Cli>用温开水送服，不建议与葡萄柚汁、咖啡等混合。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">托烷司琼（Tropisetron）\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>分为注射剂与口服剂。\u003Cbr> 注射时须稀释后静脉滴注或静推，口服宜于清晨化疗前30分钟。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">利可君（Levamisole） 片\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>口服使用，一般随餐交错服。建议用常温水吞服整片。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">胸腺法新 (Thymalfasin)\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>主要为皮下注射。正确做法：每次注射应交替部位，避免同一处反复注射。注射前可待药液回温至室温减少局部刺激。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#f8fafc 60%,#dceafd 100%)\">2️⃣ 剂型特点与服用技巧\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          奥沙利铂、托烷司琼常见为注射剂，应妥善避光保存，输注时要求专用密闭线路，杜绝空气入管。\n        \u003C/li>\n        \u003Cli>\n          卡培他滨为抗肿瘤片剂，务必整片吞服，忌粉碎或研磨（避免药物逸散和皮肤接触引发刺激）。\n        \u003C/li>\n        \u003Cli>\n          胸腺法新注射液开封后一次用尽，剩药弃去，不可二次回用。\n        \u003C/li>\n        \u003Cli>\n          利可君片剂表面存在特殊涂层，切忌嚼服或提前浸泡。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#eaf7fd 60%,#d1ecec 100%)\">3️⃣ 药品相互作用与联合用药注意\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          \u003Cb>奥沙利铂\u003C/b>禁与氯化钙、氯化钾等直接混用，亦不宜与碱性药物、5-FU混于同袋静滴。\u003Cbr>\n          \u003Cb>正确做法：\u003C/b>静滴时只用5%葡萄糖溶液为稀释剂，不得以生理盐水配伍。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>卡培他滨\u003C/b>合用抗凝药（如华法林）、苯妥英或胰岛素等可影响药物代谢和毒性，应严密监控凝血和血糖变化。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>托烷司琼\u003C/b>不建议与其它5-HT3受体拮抗剂（如昂丹司琼）合用，以免增加QT间期延长等心电风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>胸腺法新\u003C/b>与糖皮质激素合用可增强免疫抑制，慎用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>利可君\u003C/b>可影响口服降糖药、茶碱等的清除，联合用药时监测血糖/药物浓度变化。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#f7f9fa 60%,#f2e7ec 100%)\">4️⃣ 常见不良反应与对策\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Ch3 class=\"sdg-h3\">奥沙利铂\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          典型反应为手足末端感觉异常、寒觉过敏和轻到中度恶心呕吐。\u003Cb>出现呼吸困难、喉头痉挛立即停止输注。\u003C/b>\u003Cbr>\n          化疗后出现发热，应及时排查感染并与医生沟通处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">卡培他滨\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          手足皮肤红肿、胃肠反应较多（如腹泻）。一旦出现口腔溃疡、手足肿痛需暂停服药并向医师汇报处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">托烷司琼\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          可能有头晕、乏力、便秘，极少数患者会出现心律失常。若异常心悸、胸闷建议暂停，并尽快检查。\n        \u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">胸腺法新\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>局部刺痒、红肿多见，原则上3天内消退。待症状缓解后对侧继续注射，避免固定点。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"sdg-h3\">利可君\u003C/h3>\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>少数人有恶心、腹痛。若腹泻加重应暂停并就医，因个体补骨髓增殖反应不同。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"sdg-case sdg-case-tip\">\n        \u003Cspan>📍\u003C/span>有位76岁患者接受奥沙利铂方案化疗后，输注期出现发热，化疗团队及时调整给药速度，监测感染指标，未导致严重后果。\n      \u003C/div>\n      \u003Cdiv class=\"sdg-data\">\n        临床资料：奥沙利铂周围神经病变发生率可达60-80%\u003Csup>[1]\u003C/sup>，卡培他滨手足综合征约10-20%\u003Csup>[2]\u003C/sup>。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#fafae7 60%,#e9f7d3 100%)\">5️⃣ 特殊人群用药调整\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          \u003Cb>老年人：\u003C/b>奥沙利铂、卡培他滨需按肾功能调整剂量，合并其他慢病用药时尤其小心药物间干扰。\u003Cbr>\n          例如高血压、糖尿病患者须和专科医生同步调整降压药、降糖药方案。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝肾功能不全：\u003C/b>卡培他滨严重肾损害时应禁用或慎用。奥沙利铂起始剂量可酌情降低。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>孕妇及哺乳期妇女：\u003C/b>上述药物均禁止使用。怀孕期间如需应用，请严格遵医嘱。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>儿童：\u003C/b>本类药物未用于儿童常规治疗，不建议自发使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"sdg-case sdg-case-tip\">\n        \u003Cspan>👴\u003C/span>一位70岁高龄患者合并高血压、糖尿病时，化疗剂量在评估肾功能后下调1/3，有效减少了严重不良反应发生率。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#fefff5 60%,#dbe3f0 100%)\">6️⃣ 储存条件与有效期\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          \u003Cb>奥沙利铂注射液：\u003C/b>2-8°C冷藏，避光保存，配制溶液后4小时内静滴完毕。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>卡培他滨片：\u003C/b>常温干燥避光密封，勿置于潮湿及高温环境。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>托烷司琼注射剂：\u003C/b>开封后一次用完，弃去余药，原液宜冷藏。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>胸腺法新注射剂：\u003C/b>2-8°C冰箱冷藏，冻融禁用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>利可君片：\u003C/b>常温保存，防潮，勿与强氧化剂/还原剂等直接接触。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"sdg-data\">\n        \u003Cspan>🗓️ 药品失效与误服风险：\u003C/span>过期药效显著下降，不良反应发生率大幅增加。超过有效期药品，不应用于人体。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"sdg-section\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#e7f7fe 60%,#e7ece6 100%)\">7️⃣ 漏服补救与过量处理\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          \u003Cb>卡培他滨：\u003C/b>漏服时，直接跳过漏服剂量，严格按照下一次服药时间。不可一次性补服2倍剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>奥沙利铂、托烷司琼和胸腺法新注射：\u003C/b>均由专业医护操作，极少自行漏用，如因个人原因漏用应第一时间告知医生，禁止私自补注。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>利可君：\u003C/b>若漏服可于当天及时补服，但若已接近下一次服药时间则略过不补。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>过量风险：\u003C/b>以上化疗药品一旦超剂量风险极高，尤其表现为骨髓抑制、心脏毒性等，务必第一时间就诊医院救治。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \u003C!-- 总结 -->\n  \u003Csection class=\"sdg-section sdg-summary\">\n    \u003Ch2 class=\"sdg-subtitle\" style=\"background-image:linear-gradient(to right,#fc 60%,#e9ebe4 100%)\">✔️ 关键总结\u003C/h2>\n    \u003Cdiv class=\"sdg-content-block\">\n      \u003Cul class=\"sdg-list\">\n        \u003Cli>\n          围手术期化疗药品用法讲究多，奥沙利铂必须严格静滴，卡培他滨需餐后吞服，细节失守易致毒副反应。\n        \u003C/li>\n        \u003Cli>\n          各类药物联用时务必提前咨询专业药师，部分辅助药如托烷司琼、胸腺法新虽属常规，但剂量、给法均应遵循说明书及医嘱指定。\n        \u003C/li>\n        \u003Cli>\n          一旦出现严重不良反应，切勿自行中断或更改剂量，及时与医生联络，才能最大限度发挥药效、规避风险。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv class=\"sdg-callout\">\n      👉这些细节，请一定记牢并实践在每次用药中，让家人也了解正确服用、处理和存储方式，确保治疗安全。\n    \u003C/div>\n  \u003C/section>\n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"sdg-section sdg-reference\">\n    \u003Ch2 class=\"sdg-ref-title\">参考文献\u003C/h2>\n    \u003Col class=\"sdg-ref-list\">\n      \u003Cli>\n        \u003Cspan>\n          Cassidy, J., et al. (2011). \"Final results of the EORTC 40983 trial of perioperative FOLFOX4 for resectable liver metastases from colorectal cancer.\" \u003Cem>Annals of Oncology, 22\u003C/em>(12), 2742–2749. https://doi.org/10.1093/annonc/mdr385\n        \u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan>\n          Twelves, C., et al. (2005). \"Capecitabine as adjuvant treatment for stage III colon cancer.\" \u003Cem>New England Journal of Medicine, 352\u003C/em>(26): 2696–2704. https://doi.org/10.1056/NEJMoa043116\n        \u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan>\n          Roila, F. & Herrstedt, J. (2010). \"Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2009 Perugia International Antiemetic Consensus Conference.\" \u003Cem>Annals of Oncology, 21\u003C/em>(5), 232–243. https://doi.org/10.1093/annonc/mdq194\n        \u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan>\n          De Mattos-Arruda, L., & Tabernero, J. (2011). \"Colorectal cancer in 2011: towards tailored treatment.\" \u003Cem>Nature Reviews Clinical Oncology, 9\u003C/em>(2): 76–78. https://doi.org/10.1038/nrclinonc.2011.200\n        \u003C/span>\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 组件封闭样式: safe-drug-guide-root */\n.safe-drug-guide-root {\n  font-family: \"Segoe UI\", \"Arial\", sans-serif;\n  max-width: 800px;\n  margin: 24px auto 32px auto;\n  padding: 36px 24px 28px 24px;\n  background: #fff;\n  border-radius: 14px;\n  box-shadow: 0 2px 18px 3px rgba(94,101,132,.09);\n  color: #232326;\n  box-sizing: border-box;\n}\n.sdg-title {\n  font-size: 2.35em;\n  font-weight: 800;\n  text-align: center;\n  margin-bottom: 18px;\n  color: #254793;\n  letter-spacing: 0.03em;\n}\n.sdg-divider {\n  margin: 0 auto 18px auto;\n  height: 4px;\n  width: 54px;\n  background: linear-gradient(\n    90deg, #eef1f6 60%, #c5e6e3 100%);\n  border-radius: 5px;\n}\n.sdg-section {\n  margin-bottom: 32px;\n  padding-bottom: 7px;\n}\n.sdg-intro {\n  background: linear-gradient(90deg,#f7f9fa 75%,#e1edee 100%);\n  border-radius: 8px;\n  padding: 18px 20px;\n  margin-bottom: 26px;\n}\n.sdg-intro-text {\n  font-size: 1.16em;\n  line-height: 1.7;\n  color: #355269;\n  margin: 0;\n}\n.sdg-subtitle {\n  font-weight: 700;\n  font-size: 1.35em;\n  margin: 0 0 9px 0;\n  padding: 8px 14px 7px 16px;\n  border-left: 5px solid #327de6;\n  border-radius: 6px 0 0 6px;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n.sdg-content-block {\n  padding: 10px 10px 5px 23px;\n  background: #f9fb;\n  border-left: 3px solid #c3e3ed;\n  border-radius: 0 7px 7px 0;\n  box-sizing: border-box;\n}\n.sdg-list {\n  margin: 5px 0 13px 0;\n  padding-left: 24px;\n}\n.sdg-list li {\n  margin-bottom: 9px;\n  font-size: 1.03em;\n  color: #2d474d;\n  line-height: 1.7;\n}\n.sdg-h3 {\n  font-size: 1.09em;\n  font-weight: bold;\n  margin: 11px 0 7px 0;\n  color: #29739a;\n}\n.sdg-data {\n  margin-top: 11px;\n  padding:7px 14px 7px 10px;\n  background: #eef4fc;\n  color: #4667b1;\n  border-radius: 5px;\n  font-size: 0.98em;\n}\n.sdg-case {\n  margin: 13px 0px 5px 0;\n  padding: 12px 13px 10px 10px;\n  background: #fbf8f3;\n  border-left: 4px solid #fed538;\n  color: #4a3700;\n  font-size: 1.01em;\n  border-radius: 4px;\n  box-shadow: 0 2px 4px 0 rgba(255,204,90,0.05);\n  display: flex;\n  align-items: flex-start;\n  gap: 9px;\n  line-height: 1.7;\n}\n.sdg-case-tip span {\n  font-size: 1.13em;\n  margin-top: 1px;\n  color: #ffe128;\n  flex-shrink: 0;\n}\n.sdg-summary {\n  background: linear-gradient(90deg,#f7fae5 70%,#f1f1ff 100%);\n  border-radius: 9px;\n  padding: 15px 19px 16px 22px;\n}\n.sdg-callout {\n  margin: 18px 0 0 0;\n  padding: 10px 13px;\n  background: #e4f7ef;\n  border-radius: 7px;\n  border-left: 5px solid #35c08d;\n  color: #215c40;\n  font-size: 1.02em;\n  font-weight: 500;\n  line-height: 1.55;\n}\n.sdg-ref-title {\n  font-size: 1.1em;\n  font-weight: 700;\n  margin-bottom: 10px;\n  color: #355269;\n  letter-spacing: 0.01em;\n}\n.sdg-ref-list {\n  padding-left: 21px;\n  font-size: 0.99em;\n  color: #5b6778;\n}\n.sdg-ref-list li {\n  margin-bottom: 8px;\n  line-height: 1.65;\n}\n@media (max-width: 700px) {\n  .safe-drug-guide-root {padding:12px 5vw;}\n  .sdg-title {font-size:1.45em;}\n  .sdg-subtitle {font-size:1.12em;}\n}\n\u003C/style>","\u003C!-- 药品安全用药知识页 | 直肠癌T4N1M0围手术期典用药讲解 -->\n\u003Cdiv class=\"safe-drug-guide-root\">\n  \u003Ch1 id=\"material_title\"",464,"2025-12-02 02:54:32","奥沙利铂, 卡培他滨, 化疗药物, 药品安全, 癌症围手术期","了解围手术期使用的奥沙利铂、卡培他滨等化疗药物的安全用法、剂型特点和不良反应，精准掌握用药细节，确保治疗效果，尤其适合癌症患者及其家属。阅读后可有效规避用药风险。","2026-01-09 11:08:41",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]